Literature DB >> 28727941

Mucin 1 is a novel glycoprotein involved in host defense against invasive pneumococcal disease.

Jose Yuste1,2.   

Abstract

Entities:  

Keywords:  Mucin 1; Streptococcus pneumoniae; host response; phagocytosis

Mesh：

Substances：

Year:  2017        PMID： 28727941      PMCID： PMC5810498          DOI： 10.1080/21505594.2017.1356971

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  22 in total

1.  Pneumonia: the leading killer of children.

Authors:  Tessa Wardlaw; Peter Salama; Emily White Johansson; Elizabeth Mason
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

2.  TNF-α is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection.

Authors:  Seongwon Choi; Yong Sung Park; Takeshi Koga; Allison Treloar; Kwang Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

Review 3.  Mucin dynamics and enteric pathogens.

Authors:  Michael A McGuckin; Sara K Lindén; Philip Sutton; Timothy H Florin
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

Review 4.  The fundamental link between pneumococcal carriage and disease.

Authors:  Birgit Simell; Kari Auranen; Helena Käyhty; David Goldblatt; Ron Dagan; Katherine L O'Brien
Journal:  Expert Rev Vaccines       Date:  2012-07       Impact factor: 5.217

5.  Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.

Authors:  Michael A McGuckin; Alison L Every; Caroline D Skene; Sara K Linden; Yok Teng Chionh; Agnieszka Swierczak; Julie McAuley; Stacey Harbour; Maria Kaparakis; Richard Ferrero; Philip Sutton
Journal:  Gastroenterology       Date:  2007-07-10       Impact factor: 22.682

6.  SIGN-R1 contributes to protection against lethal pneumococcal infection in mice.

Authors:  Astrid Lanoue; Menna R Clatworthy; Philippa Smith; Sheila Green; Michael J Townsend; Helen E Jolin; Kenneth G C Smith; Padraic G Fallon; Andrew N J McKenzie
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

7.  Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.

Authors:  Cheng-Lung Ku; Horst von Bernuth; Capucine Picard; Shen-Ying Zhang; Huey-Hsuan Chang; Kun Yang; Maya Chrabieh; Andrew C Issekutz; Coleen K Cunningham; John Gallin; Steven M Holland; Chaim Roifman; Stephan Ehl; Joanne Smart; Mimi Tang; Franck J Barrat; Ofer Levy; Douglas McDonald; Noorbibi K Day-Good; Richard Miller; Hidetoshi Takada; Toshiro Hara; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; David Speert; Damien Sanlaville; Xiaoxia Li; Frédéric Geissmann; Eric Vivier; László Maródi; Ben-Zion Garty; Helen Chapel; Carlos Rodriguez-Gallego; Xavier Bossuyt; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

8.  The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.

Authors:  Mohamed Arredouani; Zhiping Yang; YaoYu Ning; Guozhong Qin; Raija Soininen; Karl Tryggvason; Lester Kobzik
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

9.  PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease.

Authors:  Elisa Ramos-Sevillano; Ana Urzainqui; Belén de Andrés; Rafael González-Tajuelo; Mirian Domenech; Fernando González-Camacho; Francisco Sánchez-Madrid; Jeremy S Brown; Ernesto García; Jose Yuste
Journal:  PLoS Pathog       Date:  2016-03-14       Impact factor: 6.823

Review 10.  Mucins in the mucosal barrier to infection.

Authors:  S K Linden; P Sutton; N G Karlsson; V Korolik; M A McGuckin
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.